Список литературы

1. Кокосадзе Н.В., Пробатова Н.А., Ковригина А.М., и соавт. Морфологическая диагностика MALT-лимфомы желудка. Вестник Московского онкологического общества. 2009; 10: 2 - 4

2. Поддубная И.В., Османов Е.А., Москаленко О.А., и соавт. Клинические аспекты MALT-лимфом. Вестник Московского онкологического общества. 2009; 10: 5 - 6

3. Поддубная И.В. Неходжкинские лимфомы маргинальной зоны. "Гериатрическая гематология. Заболевания системы крови в старших возрастных группах". Под редакцией Л.Д. Гриншпун, А.В. Пивника. 2012; 2: 176 - 187

4. Маев И.В., Самсонов А.А., Андреев Д.Н., Кочетов С.А. Эволюция представлений о диагностике и лечении инфекции Helicobacter pylori (по материалам консенсуса Маастрихт, Флоренция, 2010). Вестник практического врача. Спецвыпуск 1. 2012

5. Malfertheiner P, Megraud F, O'Morain C, et al. Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut. 2012; 61: 646 - 664

6. Kahl B, Yang D. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL. Hematology Am Soc Hematol Educ Program. 2008: 359 - 64

7. Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology Am Soc Hematol Educ Program. 2005: 307 - 13

8. Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumors of haematopoietic and lymphoid tissues (ed 4th). Lyon: IARC; 2008

9. Nathwani BN, Anderson JR, Armitage JO, et al. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin"s Lymphoma Classification Project. J Clin Oncol. 1999; 17(8): 2486 - 92

10. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997; 15(4): 1624 - 30

11. Малихова О.А., Поддубный Б.К., Поддубная И.В., и соавт. Неходжкинские лимфомы желудка: современное состояние проблемы. Экспериментальная и клиническая гастроэнтерология. 2010; 9: 33 - 37

12. Малихова О.А., Черкес Л.В., Кувшинов Ю.П., и соавт. Эндоскопическая и эндосонографическая диагностика неходжкинских лимфом желудка. Клиническая онкогематология. 2012; 5(4): 305 - 315

13. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003; 101(7): 2489 - 95

14. Ye H, Liu H, Raderer M, et al. High incidence of t(11; 18) (q21; q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood. 2003; 101(7): 2547 - 50

15. Rohatiner A, d"Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994; 5(5): 397 - 400

16. Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol. 2009; 20(6): 1086 - 93

17. Andriani A, Miedico A, Tedeschi L, et al. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis. 2009; 41(7): 467 - 73

18. Nakamura S, Matsumoto T, Suekane H, et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer. 2005; 104(3): 532 - 40

19. Vrieling C, de Jong D, Boot H, et al. Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Radiother Oncol. 2008; 87(3): 405 - 11

20. ESMO Guidelines Working Group. Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21 (Suppl 5): v175 - 6.

21. Goda JS, Gospodarowicz M, Pintilie M, et al. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer. 2010; 116(16): 3815 - 24.

22. Martinelli G, Laszlo D, Ferreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin"s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005; 23(9): 1979 - 83

23. Шаленков В.А., Неред С.Н., Поддубная И.В., Стилиди И.С. Место хирургии в лечении осложненных форм неходжкинских лимфом желудочно-кишечного тракта. Клиническая онкогематология. 2012; 5(4): 338 - 348

24. Arcaini L, Burcheri S, Rossi A, et al. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. Oncologist. 2006; 11(3): 285 - 91

25. Kelaidi C, Rollot F, Park S, et al. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia. 2004; 18(10): 1711 - 6

26. Vallisa D, Bernuzzi P, Arcaini L, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin"s lymphoma: a multicenter Italian experience. J Clin Oncol. 2005; 23(3): 468 - 73

27. Arcaini L, Vallisa D, Merli M, et al. Hematological response to antiviral treatment in 94 patients with indolent B-cell lymphomas associated with hepatitis C virus infection: a study of the Fondazione Italiana Linfomi (FIL). Ann Oncol 2011; 22 (Supp 4): Abstract 138

28. Tsimberidou AM, Catovsky D, Schlette E, et al. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer. 2006; 107(1): 125 - 35

29. Cervetti G, Galimberti S, Sordi E, et al. Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL). Ann Oncol. 2010; 21(4): 851 - 4.

30. Milosevic R, Todorovic M, Balint B, et al. Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma. World J Gastroenterol. 2009; 15(32): 4009 - 4015